SSelectStock

VENUSREMVenus Remedies Limited

Pharma · Drug Manufacturers - Specialty & Generic · NSE

Venus Remedies Limited engages in the pharmaceutical business in India, Latin America, Europe, the Middle East, Africa, Asia, and internationally. The company is involved in the research and development of solutions focusing on antimicrobial resistance, oncology, skin and wound care, and pain management. It also provides analgesic, analgesic and antipyretic, antibiotic, antidiabetic anticoagulant, antiemetic, antiviral, cardiac, cardiovascular, CNS, disinfectant and antiseptic, gastro therapy, gastro therapy, hepatoprotective, hormones (steroid), immunostimulating agent, iron supplements, mucolytic, muscle relaxant, neurology, respiratory, stress reliver, urology, vitamins, nutrients, minerals, and solvent products, as well as herbal medicine. The company was incorporated in 1989 and is headquartered in Panchkula, India.

₹—
—

Mkt Cap
₹2,233 Cr
P/E
19.2
P/B
3.4
Div Yield
0.60%
52W High
—
52W Low
—

Price & Volume

Loading chart…

Key Ratios

Market Cap (₹ cr)2,232.80
P/E19.19
P/B3.36
PEG0.14
ROE %15.50
ROCE %15.80
Debt / Equity0.02
EPS86.93
Revenue Growth %35.60
Profit Growth %139.30
Dividend Yield %0.60
Promoter Holding %48.62
FII Holding %1.39
DII Holding %—
Beta0.35

“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.

Active Pattern Signals

None of the 16 pattern scanners currently detects a setup on VENUSREM — signals appear here automatically when one forms (checked on every data refresh). The Trade Plan on the right always provides stop-loss and target levels regardless.